This Certificate of Analysis covers Quto Blue Razz Kratom Tablets (Batch: PO250326), tested and verified by PharmLabs San Diego. The sample, identified as SD250506-010, was analyzed for its Kratom alkaloid profile, including 7-Hydroxy Mitragynine, Mitragynine, Speciogynine, and Speciociliatine.
- Product Type: Edible Tablets
- Total Tablet Weight: 5.124 g
- Number of Servings: 10
- Serving Size: 0.51 g
- Main Active Alkaloid:
- 7-Hydroxy Mitragynine: 6.86% (351.40 mg per unit)
No other alkaloids were detected in this batch. Testing was conducted using HPLC VWD under SOP-KTM protocol.
This batch passed QA testing standards and complies with ISO/IEC 17025:2017 accreditation. Results reflect the sample as received on May 5, 2025, and reported on May 7, 2025.